Food Allergy Treatment Market Size Report 2034 | Aimmune Therapeutics, Inc., Novartis, DBV Technologies, InnoUp Farma S.L., COUR Pharmaceutical Development Company Inc., Vedanta Biosciences

DelveInsight's "Food Allergy Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the food allergy, historical and forecasted epidemiology and the food allergy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Discover Key Insights into the Food Allergy Market with DelveInsight's In-Depth Report @ Food Allergy Market Size- https://www.delveinsight.com/sample-request/food-allergy-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Food Allergy Market Report
• In March 2025:- ALK-Abelló A/S conducted a study investigates the safety, tolerability and efficacy of a peanut SLIT-tablet in adults, adolescents, and children with peanut allergy. This is a phase I/II, dose-escalation, multi-site trial including subjects with peanut allergy confirmed by screening double-blind, placebo-controlled food challenge.
• DelveInsight's analyst estimate that approximately 57.5 million Prevalent Cases of Food Allergy were found in 2023 in the 7MM.
• The United States exhibited the highest diagnosed prevalent population of food allergy, as compared to other 7MM countries. As per DelveInsight's estimations, the Total Prevalent Cases of Food Allergy in the US was around 33.1 million in 2023 and is projected to increase during the forecast period owing to the increasing awareness among the patient population and launch of novel therapies.
• According to DelveInsight's estimates, the Total Prevalent Cases of Food Allergy in EU4 and the UK were found to be ~16.9 million in 2023. Throughout the study period, it is anticipated that there will be a substantial increase in cases for all contributing countries, except for Germany, where the cases are expected to decrease. The highest proportion of Food Allergy cases was reported in Spain among the EU4 countries, while the least number of cases was found in the UK.
• The estimates show the Total Prevalent Cases of Food Allergy in Japan was found to be around 7.4 million in 2023, which is estimated to decrease by 2034.
• In the US, food allergy cases were classified by specific causes such as Cow Milk, Peanut, Eggs, Wheat, Treenuts, Fish, Shellfish, Soy, and Others. Shellfish accounted for the most prevalent cases, approximately 8 million, in 2023.
• According to the analysis performed by DelveInsight's experts, the Age-specific Cases of Food Allergy were categorized into Children, and Adults. The higher number of cases (~28 million) was accounted for by the Adults in 2023 in the US.
• The leading Food allergy Companies such as Aimmune Therapeutics, Inc., Novartis, DBV Technologies, InnoUp Farma S.L., COUR Pharmaceutical Development Company Inc., Vedanta Biosciences, Inc., Regeneron Pharmaceuticals, Genentech, Inc., Rho Federal Systems Division, Inc., Alladapt Immunotherapeutics, Inc., Camallergy, and others.
• Promising Food allergy Therapies such as Ligelizumab 120 mg, Dupilumab, Omalizumab, and others.

Stay ahead in the Food Allergy Therapeutics Market with DelveInsight's Strategic Report @ Food Allergy Market Outlook- https://www.delveinsight.com/sample-request/food-allergy-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Food Allergy Epidemiology Segmentation in the 7MM
• Food Allergy Prevalent cases
• Prevalent Cases of Food Allergy based on Etiology-specific Factors
• Food Allergy Age-specific Prevalence Cases

Download the report to understand which factors are driving Food Allergy epidemiology trends @ Food Allergy Prevalence- https://www.delveinsight.com/sample-request/food-allergy-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Food Allergy Marketed Drugs
• Palforzia: Aimmune Therapeutics, Inc.
Approved in 2020, Palforzia is a complex biologic drug used with a structured dosing approach that builds on a century of oral immunotherapy (OIT) research. With OIT, the specific allergenic proteins are ingested initially in very small quantities, followed by incrementally increasing amounts, resulting in the ability to mitigate allergic reactions to the allergen over time. Palforiza is the first approved treatment for patients with peanut allergy. It is oral immunotherapy indicated to mitigate allergic reactions, including anaphylaxis that may occur with accidental exposure to peanuts. Palforzia is approved for use in patients with a confirmed diagnosis of peanut allergy.

Food Allergy Emerging Drugs
• Ligelizumab: Novartis Pharmaceuticals
Ligelizumab (QGE031), a humanized anti-IgE antibody developed by Novartis, is a next-generation monoclonal anti-immunoglobulin E (IgE) antibody. It is also directed against Cε3, but is designed to achieve improved IgE suppression, with an equilibrium dissociation constant (KD) of 139 pM (as compared to the KD of omalizumab, ~6-8 nm). Ligelizumab's mechanism of action involves blocking the IgE/FcεRI pathway, a key driver of the inflammatory process in CSU (chronic spontaneous urticaria), and binding with high affinity to the Cε3 domain of IgE.

• Viaskin Peanut: DBV Technologies
Viaskin Peanut is the first epicutaneous immunotherapy (EPIT) in development that leverages the skin to activate the immune system and induce desensitization in peanut-allergic children. EPIT aims to target specific epidermal dendritic cells, called Langerhans cells. Pre-clinical research has shown that these cells capture antigens and migrate to the lymph node in order to activate the immune system. By delivering the allergen directly to the lymph node through the Langerhans cells, pre-clinical research has shown that EPIT activates specific regulatory T cells (Tregs) that can down-regulate the Th2-oriented reaction to the allergen.

Get In-Depth Knowledge on Food Allergy Market Trends and Forecasts with DelveInsight @ Food Allergy Treatment Market- https://www.delveinsight.com/sample-request/food-allergy-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Food Allergy Market Outlook
Food allergy has a diverse treatment classification associated with the disease landscape. The management of food allergy primarily revolves around the utilization of Epinephrine, Anti-histamines, Steroids, Beta-2-agonists, and Palforzia as needed. Palforzia is the major revenue generator in the current treatment landscape. The Food Allergy market is expected to experience positive growth with the approval of potential drugs like Ligelizumab (QGE031), Viaskin Peanut, Omalizumab, and others.

Food Allergy Market Dynamics
The Food Allergy market dynamics are anticipated to change in the coming years owing to the expected launch of emerging therapies by major key players in the treatment regime. The launch of various multiple-stage pipeline products will significantly revolutionize the Food Allergy market dynamics shortly. The emerging drug analysis along with their detailed profiling is done by the DelveInsight.

Unlock Strategic Insights with DelveInsight's Comprehensive Food Allergy Market Report @ Food Allergy Market Drivers and Barriers- https://www.delveinsight.com/sample-request/food-allergy-market-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Food Allergy Market Report
• Coverage- 7MM
• Study Period- 2020-2034
• Food Allergy Companies- Aimmune Therapeutics, Inc., Novartis, DBV Technologies, InnoUp Farma S.L., COUR Pharmaceutical Development Company Inc., Vedanta Biosciences, Inc., Regeneron Pharmaceuticals, Genentech, Inc., Rho Federal Systems Division, Inc., Alladapt Immunotherapeutics, Inc., Camallergy, and others.
• Food allergy Therapies- Ligelizumab 120 mg, Dupilumab, Omalizumab, and others.
• Food Allergy Therapeutic Assessment: Food Allergy current marketed and Food Allergy emerging therapies
• Food Allergy Market Dynamics: Food Allergy market drivers and Food Allergy market barriers
• Food Allergy Unmet Needs, KOL's views, Analyst's views, Food Allergy Market Access and Reimbursement

Table of Content
1 Key Insights
2 Report Introduction
3 Food Allergy Market Overview at a Glance
4 Methodology of Food Allergy Epidemiology and Market
5 Executive Summary of Food Allergy
6 Key Events
7 Disease Background and Overview
8 Epidemiology and Patient Population
9 Patient Journey
10 Marketed Therapies
11 Emerging Drugs
12 Food Allergy: Seven Major Market Analysis
13 KOL Views
14 SWOT Analysis
15 Unmet Needs
16 Market Access
17 Appendix
18 DelveInsight Capabilities
19 Disclaimer
20 About DelveInsight

List of Top Selling Market Research Reports in 2025

Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/underactive-bladder-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Surgical robotic system market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical sealant market - https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Trichotillomania market- https://www.delveinsight.com/sample-request/trichotillomania-ttm-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.